Clinical Trial Update: The DAWN Antivirals Trial for Ambulatory COVID-19 Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for the DAWN Antivirals Trial in ambulatory COVID-19 patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Snippet

Sponsor: KU Leuven | Conditions: Covid19, SARS-CoV Infection | Phase 3 | Status: TERMINATED